CVKD Insider Trading Activity and SEC Form 4 Filings
CVKD insider trading summary
Over the past 12 months, insiders at Cadrenal Therapeutics, Inc. (CVKD) reported 20 sales worth $421K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $421K.
Latest CVKD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Quang X Pham | Chairman and CEO | Sell | $22K (7,400 @ $3.03) |
| Jun 26, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $28K (9,029 @ $3.05) |
| Jun 25, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $6K (2,127 @ $3.00) |
| Jun 23, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $7K (2,277 @ $3.20) |
| Jun 22, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $33K (9,167 @ $3.55) |
| Jun 17, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $2K (513 @ $3.16) |
| Jun 16, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $11K (3,613 @ $3.18) |
| Jun 15, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $13K (3,666 @ $3.58) |
| Jun 12, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $51K (12,996 @ $3.94) |
| Jun 11, 2026 | Quang X Pham | Chairman, CEO and Interim CFO | Sell | $6K (1,462 @ $4.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.